Difference between revisions of "Microphthalmia transcription factor"
Jump to navigation
Jump to search
(Created page with "'''Microphthalmia transcription factor''', abbreviated '''MITF''', is a common immunostain in the diagnosis of malignant melanoma. ==References== {{Reflist|1}} C...") |
(teak) |
||
| Line 1: | Line 1: | ||
'''Microphthalmia transcription factor''', abbreviated '''MITF''', is a common [[immunostain]] in the diagnosis of [[malignant melanoma]]. | '''Microphthalmia transcription factor''', abbreviated '''MITF''', is a common [[immunostain]] in the diagnosis of [[malignant melanoma]]. | ||
==General== | |||
MITF is a in the ''microphthalmia'' (abbreviated ''MiT'') subfamily of transcription factors that also inclues TFE3, TFEB, TFEC.<ref>{{cite journal |vauthors=Xie L, Zhang Y, Wu CL |title=Microphthalmia family of transcription factors associated renal cell carcinoma |journal=Asian J Urol |volume=6 |issue=4 |pages=312–320 |date=October 2019 |pmid=31768316 |pmc=6872788 |doi=10.1016/j.ajur.2019.04.003 |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 15:27, 5 November 2021
Microphthalmia transcription factor, abbreviated MITF, is a common immunostain in the diagnosis of malignant melanoma.
General
MITF is a in the microphthalmia (abbreviated MiT) subfamily of transcription factors that also inclues TFE3, TFEB, TFEC.[1]
References
- ↑ "Microphthalmia family of transcription factors associated renal cell carcinoma". Asian J Urol 6 (4): 312–320. October 2019. doi:10.1016/j.ajur.2019.04.003. PMC 6872788. PMID 31768316. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872788/.